Fezolinetant significantly reduces vasomotor symptoms in post-menopausal women
1. Fezolinetant 30 mg and 45 mg significantly reduced the frequency and severity of vasomotor symptoms compared to placebo. 2. ...
Tag: menopause
Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab reduce postmenopausal fracture risk
1. Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab use are associated with reduced clinical fractures in postmenopausal patients with osteoporosis. 2. ...
#VisualAbstract: Tamoxifen increases the risk of endometrial cancer in premenopausal women with breast cancer
Click to read this study in JAMA Network Open.
Endometriosis associated with early natural menopause
1. This prospective study, using the US Nurses’ Health Study cohort, demonstrated a significantly higher risk of early natural menopause ...
Fractional carbon dioxide laser not effective for treatment of postmenopausal vaginal symptoms
1. A randomized controlled trial of 85 participants found no significant difference in vaginal symptom severity after 12 months between ...
Relationships between depression and anxiety symptoms and adipocyte-derived proteins in postmenopausal women
1. High adiponectin and low leptin levels were associated with greater anxiety and depression symptoms in postmenopausal women. Evidence Rating ...
Hormone replacement therapy not associated with changes in mortality in post-menopausal women
1. In this analysis of two randomized controlled trials, hormone replacement therapy (HRT) was not associated with a change in ...
Use of plant-based therapies and menopausal symptoms
1. This systematic review found that there was an association between overall phytoestrogen use and the degree of hot flashes ...
Paroxetine a good non-hormonal option for hot flashes
1. Paroxetine use was associated with decreased frequency of hot flashes and lower composite vasomotor symptom (VMS) severity score. 2. ...
